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Abstract
Background: Sepsis and septic shock are major healthcare problems, affecting millions of individuals around the
world each year. Pathophysiologically, septic multiple organ dysfunction (MOD) is a life-threatening condition
caused by an overwhelming systemic inflammatory response of the host’s organism to an infection. We experimentally
tested if high circulating cytokine levels might increase vascular permeability—a critical hallmark of the disease—and if
this phenomenon can be reversed by therapeutic cytokine removal (CytoSorb®) in an exemplary patient.
Case presentation: A 32-year-old Caucasian female presented with septic shock and accompanying acute kidney
injury (Sequential Organ Failure Assessment (SOFA) = 18) to our ICU. In spite of a broad anti-infective regimen,
adequate fluid resuscitation, and high doses of inotropics and catecholamines, she remained refractory hypotensive. The
extraordinary severity of septic shock suggested an immense overwhelming host response assumingly accompanied by
a notable cytokine storm such as known from patients with toxic shock syndrome. Thus, a CytoSorb® filter was added
to the dialysis circuit to remove excess shock-perpetuating cytokines. To analyze the endothelial phenotype in vitro
before and after extracorporeal cytokine removal, we tested the septic shock patient’s serum on human umbilical vein
endothelial cells (HUVECs). The effect on endothelial integrity was assessed both on the morphological (fluorescent
immunocytochemistry for VE-cadherin and F-actin) and functional (transendothelial electrical resistance (TER)) level that
was recorded in real time with an “electric cell-substrate impedance sensing” (ECIS) system (ibidi). We found (1) severe
alterations of cell-cell contacts and the cytoskeletal architecture and (2) profound functional permeability changes, the
putative cellular correlate of the clinical vascular leakage syndrome. However, the endothelial barrier was protected from
these profound adverse effects when HUVECs were challenged with septic shock serum that was collected after
extracorporeal cytokine removal.
Conclusions: Beneficial observations of extracorporeal cytokine removal in septic shock patients might—at least
in part—be promoted via protection of vascular barrier function.
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Background
Sepsis is defined as life-threatening organ dysfunction
caused by a dysregulated host response to an (often local)
infection [1]. Most people do not die from the infection per
se but rather from their own overwhelming (inflammatory)
response [2]. While the immune system is undoubtedly
important in the development of the disease, somewhat less
attention has been given to the microvasculature. The
endothelium pervades every organ and is responsible for a
variety of physiological functions that can be altered in
sepsis [3]. The net result is that the septic endothelium pre-
sents a pro-coagulant, pro-adhesive surface, fails to produce
its usual profile of vasoconstrictive and vasodilatory com-
pounds, and suffers a loss of normal barrier function. Of
these changes, increased vascular permeability may be par-
ticularly important because it gives rise to hypovolemia and
contributes to hemoconcentration, stasis of blood flow, and
shock. Thus, systemic vascular changes have severe conse-
quences for organ function and barrier breakdown directly
contributing to multiple organ dysfunction (MOD) [4].
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The potential of cytokines such as TNFα to induce
vascular leakage has been reported. Rather than looking
at the immune system and the microvasculature separ-
ately as two distinct entities, we wanted to further analyze
the link between both systems in a clinical meaningful
context. To do this, we used serum from an exemplary
septic individual before and after extracorporeal cytokine
removal and tested its effect on endothelial morphology
and function in vitro.
Case presentation
A 32-year-old Caucasian female with a 4-day history of
fever, malaise, and cough was found unconscious and
hypoxic by the emergency team. She was successfully re-
suscitated and after initial treatment at a local hospital
transferred to our institution for extracorporeal mem-
brane oxygenation (ECMO) due to influenza pneumonia,
which caused respiratory failure and severe ARDS. She
also had an abscess of her left breast that grew Escherichia
coli bacteria. Due to sepsis (peak CRP 222 mg/L; peak pro-
calcitonin 81.2 μg/L) and accompanying acute kidney
injury (AKI), the patient required additional organ support
by continuous veno-venous hemodialysis (CVVHD).
Sequential Organ Failure Assessment (SOFA) score was
18. The patient remained refractory hypotensive despite
a broad anti-infective regimen, adequate fluid resuscita-
tion, and high doses of inotropics and catecholamines.
The severity of septic shock suggested an immense
overwhelming host response assumingly accompanied
by a notable cytokine storm such as known from pa-
tients with toxic shock syndrome. Longitudinal clinical
and laboratory findings are summarized in Table 1.
Additionally, a CytoSorb® filter was added for a single
24-h session to the dialysis circuit to remove excess
shock-perpetuating cytokines. After 24 h of treatment,
the mean arterial pressure (MAP) could be maintained
above 65 mmHg with markedly reduced need for vaso-
pressors, now even allowing the removal of excessive
fluids by ultrafiltration. A clinical observation that might
be indicative for stabilization of vascular alterations as-
sumed to contribute to the development and maintenance
of shock (such as loss of tone and barrier breakdown).
Unfortunately, clinical and radiologic signs of severe
hypoxic brain injury forced us to switch our therapeutic
strategy to comfort care and the patient died the next day.
Cytokine, chemokine, and growth factor concentrations
in supernatants in serum from our patient were quantified
by the Luminex-based multiplex technique according to
the manufacturer’s instructions (Bio-Rad, USA). Efficacy
of cytokine removal by extracorporeal CytoSorb® could be
confirmed by comparing pre-treatment and 24 h cytokine
levels (Table 2). The observation that some cytokines in-
creased during the treatment might be due to a high bio-
synthesis overreaching the removal rate. Of note, pre- and
post-CytoSorb® drug levels of antibiotics yielded a 76%
reduction for meropenem (25.5 to 6.4 μg/mL) and a 58%
reduction for piperacillin (11.7 to 4.9 μg/mL). Clindamy-
cin was only reduced by 15% comparing pre- and post-
adsorber concentration (14.0 to 11.9 μg/mL). Based on
this observation, we highly recommend a thorough thera-
peutic drug monitoring in septic patients when using
extracorporeal removal strategies.
Most notably from the clinical point of view, we found
improved hemodynamic stability within the process of
cytokine removal (Table 1). In order to experimentally
analyze putative cellular effects of the cytokine removal
on the vasculature, we used a previously described cellu-
lar in vitro system [5]. We therefore collected serum
from this patient immediately before and 24 h after cyto-
kine removal. ECs were then challenged with these serial
Table 1 Clinical and laboratory findings
Parameter Pre +12 h +24 h (post)
Cytokine removal
Hemodynamics
Heart rate (bpm) 107 120 111
MAP (mmHg) 58 62 70
NA dose (μg/kg/min) 0.40 0.11 0.09
Respiration
PaO2/FiO2 65 68 120
PEEP/ΔP 15/20 15/19 15/18
ECMO
Pump (rpm) 3650 3650 3650
Blood flow (L) 3.6 3.72 3.54
FiO2 (%) 100 100 100
Gas flow (L) 4 4 4
Renal function
Creatinine (μmol/L) 242 – 70
pH 7.26 7.49 7.47
HCO3− (mmol/L) 18 20 21
Lactate (mmol/L) 3.1 1.8 0.9
UO (mL/h) ±2 h 15 0 0
UF (mL) ±12 h 0 −1200 −4900
Lab parameters
CRP (mg/L) 222 149 187
PCT (μg/L) 81.2 60.4 34.4
INR 1.45 – 1.18
WBC (1/nL) 41.4 – 23.6
PLT (1/nL) 92 – 41
Hb (g/dL) 12.1 – 10.5
NA noradrenaline, MAP mean arterial pressure, PEEP positive end-expiratory
pressure, P pressure, UO urine output, UF ultrafitration, CRP C-reactive protein,
PCT procalcitonine, INR international normalized ration, WBC white blood cells,
PLT platelets, Hb hemoglobin
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human serum samples for 30 min, and their morphology
was investigated by fluorescent immunocytochemistry
for the adherence junction protein VE-cadherin (green)
and for a major component of the cytoskeleton, i.e., F-
actin (red). Of note, intense stress on ECs leads to a
polymerization of F-action resulting in the formation of
so-called stress fibers. These contraction forces from the
cytoskeletal architecture then contribute to the forma-
tion of visible gaps between adjacent cells, the cellular
correlate for the clinical “vascular leakage syndrome”
(Fig. 1, middle panel). When ECs were challenged with
serum from the same patient after cytokine removal, the
cells showed slightly less formation of stress fibers and
were protected from the development of intracellular
gaps (Fig. 1, right panel). All together, the endothelial
phenotype after cytokine removal was comparable to
cells that were stimulated with serum from a healthy
control person (Fig. 1, left panel).
Next, TER measurements were performed in real time
to objectively quantify the functional permeability conse-
quences of these intercellular gaps [6]. ECs were incu-
bated with our patient’s serum before and after cytokine
removal analogously to the staining experiment. Serial
TERs were recorded every minute with a real-time elec-
tric cell-substrate impedance sensing (ECIS) approach in
triplicates over 120 min. ECs challenged with serum be-
fore cytokine removal showed a rapid drop in mean re-
sistance (consistent with an increase in permeability)
(Fig. 2, bold line) whereas serum from the same patient
Table 2 Cytokine, chemokine, and growth factor removal 24 h
after Cytosorb® treatment
Parameter Pre Post Rel. reduction (%)
Cytokine removal (pg/mL)
IL-1a 643.9 76 −88.2
IL-6 89.9 14.0 −84.4
CXCL8 (IL-8) 68.4 19.9 −70.9
IL-9 12.9 7.2 −44.2
IL-10 80.7 40.0 −49.6
IL-13 7.1 10.8 +51.5
FGF 48.1 21.4 −55.6
GM-CSF 57.5 38.6 −32.9
CXCL10 (IP-10) 24,723.7 2827.5 −88.6
CCL2 (MCP-1) 375.0 45.9 −87.8
CCL4 (MIP-1b) 125.4 39.2 −68.8
PDGF-bb 719.8 245.3 −65.9
RANTES 3912.2 1326.1 −66.1
TNF-a 59.2 24.8 −58.1
VEGF 63.7 19.5 −69.5
IL interleukin, CXCL C-X-C motif chemokine, FGF fibroblast growth factor,
GM-CSF granulocyte-macrophage colony-stimulating factor, IP interferon
gamma produced protein, CCL C-C motif ligand, MIP macrophage inflammatory
proteins, MCP monocyte chemotactic protein, PDGF platelet-derived growth
factor, RANTES regulated on activation, normal T cell expressed and secreted,
TNF tumor necrosis factor, VEGF vascular endothelial growth factor
Fig. 1 Endothelial phenotype with respect to barrier function. Fluorescence immunocytochemistry staining for vascular endothelial (VE)-cadherin
(green), F-actin (red), was performed on confluent human umbilical vein endothelial cells (HUVECs) as described before [5]. Cells were treated for
30 min with media supplemented with 5% serum from an individual with septic shock before
(2nd row) and after cytokine removal (3rd row); 5% healthy human serum served as a control (1st row). Scale bar 10 μm
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after cytokine removal evidently blunted the permeability
response (Fig. 2, dotted line).
Discussion
Here, we report a case of a severely septic patient with
multiple organ failure that was treated with a combin-
ation of ECMO and CVVHD. Additional extracorporeal
cytokine removal (i.e., CytoSorb®) led to a stabilization of
septic shock within hours. Consistent with the hypothesis
of a putative interplay between circulating cytokines and
altered vascular permeability, we found in cultured ECs
that circulating cytokines in septic shock can indeed nega-
tively affect the vascular barrier. One possible approach to
remove circulating cytokines could be via modern absorp-
tion techniques in particular in those individuals that do
require an extracorporeal circuit nevertheless, e.g., for
renal replacement or membrane oxygenation therapies.
Similar to our patient, the feasibility of combining these
extracorporeal devices together with a cytokine removing
filter has been exemplary reported in another case in
sepsis [7].
Our side observation of lowered antibiotic serum
levels is of clinical relevance and highlights the import-
ance of a thorough therapeutic drug monitoring and
eventual dose adaptation during modern therapeutic
cytokine removal strategies. The same might be true for
other protective circulating factors as we have observed
with respect to the anti-proliferative cytokine IL-10 in
our patient (Table 2). The interaction between the im-
mune system and the microvasculature in the pathogen-
esis of septic MOD is of particular interest for two main
reasons: (1) ECs represent a direct interface between
circulating (potentially harmful) cytokines covering vir-
tually all organs and (2) increased permeability with con-
secutive excessive leakage of intravascular fluids to the
interstitial space has increasingly been recognized as a
hallmark of MOD and death in sepsis [3, 4]. However, in
light with the relatively low absolute cytokine levels
before removal, one has to consider that endothelial im-
provement might be due to off-target removal of other
permeability inducing factors.
Conclusions
Consistent with the concept that circulating cytokines
interact with the endothelial surface layer and these cy-
tokines can induce pathological vascular permeability,
we observed profound alterations of the endothelial
morphology and function when challenged with human
septic shock serum in vitro. These cellular changes—that
clinically represent the vascular barrier breakdown—were
not detectable when serum from the same patient after
extracorporeal cytokine removal was used. From this ex-
emplary single patient, we assume that extracorporeal
cytokine absorption techniques (such as CytoSorb®) might
have protective effects on vascular integrity. No doubt that
this report from a single patient is hypothesis generating in
nature so that a future systematic study is highly desirable.
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Fig. 2 Transendothelial resistance (TER) of HUVECs treated with septic serum. Normalized transendothelial electrical resistance (TER) was longitudinally
measured in real time in human umbilical vein endothelial cells (HUVECs) with an electric cell-substrate impedance sensing (ECIS) device. HUVECs were
then challenged with either septic serum before cytokine removal (bold line) or with serum from the same patient 24 h after cytokine removal (dotted line).
TER normalization refers to the start point of the experiment for each condition (i.e., 5 min before septic serum incubation)
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